Dallas, TX

Key-Whitman Eye Center

Cataract

Presbyopia

Astigmatism

Aphakia

Eye Diseases

Pseudophakia

Postcataract Aphakia

AGN-190584

Nepafenac

Mitomycin C

Pilocarpine HCl

Johnson & Johnson (J&J)

ReVision Optics

STAAR Surgical

Allergan

Abbott

Actavis

Alcon

Beaver-Visitec

RxSight

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Key-Whitman Eye Center | Dallas, TX

Site insights

Work at this site?

Active trials

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Trial sponsors